Literature DB >> 25152259

Mortality of induced abortion, other outpatient surgical procedures and common activities in the United States.

Elizabeth G Raymond1, Daniel Grossman2, Mark A Weaver3, Stephanie Toti4, Beverly Winikoff5.   

Abstract

OBJECTIVE: The recent surge of new legislation regulating induced abortion in the United States is ostensibly motivated by the desire to protect women's health. To provide context for interpreting the risk of abortion, we compared abortion-related mortality to mortality associated with other outpatient surgical procedures and selected nonmedical activities.
METHODS: We calculated the abortion-related mortality rate during 2000-2009 using national data. We searched PubMed and other sources for contemporaneous data on mortality associated with other outpatient procedures commonly performed on healthy young women, marathon running, bicycling and driving.
RESULTS: The abortion-related mortality rate in 2000-2009 in the United States was 0.7 per 100,000 abortions. Studies in approximately the same years found mortality rates of 0.8-1.7 deaths per 100,000 plastic surgery procedures, 0-1.7deaths per 100,000 dental procedures, 0.6-1.2 deaths per 100,000 marathons run and at least 4 deaths among 100,000 cyclists in a large annual bicycling event. The traffic fatality rate per 758 vehicle miles traveled by passenger cars in the United States in 2007-2011 was about equal to the abortion-related mortality rate.
CONCLUSIONS: The safety of induced abortion as practiced in the United States for the past decade met or exceeded expectations for outpatient surgical procedures and compared favorably to that of two common nonmedical voluntary activities. The new legislation restricting abortion is unnecessary; indeed, by reducing the geographic distribution of abortion providers and requiring women to travel farther for the procedure, these laws are potentially detrimental to women's health.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abortion; Bicycling; Driving; Marathon; Mortality; Outpatient surgery

Mesh:

Year:  2014        PMID: 25152259     DOI: 10.1016/j.contraception.2014.07.012

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  7 in total

1.  A 21st-Century Public Health Approach to Abortion.

Authors:  Sarah C M Roberts; Liza Fuentes; Nancy F Berglas; Amanda J Dennis
Journal:  Am J Public Health       Date:  2017-10-19       Impact factor: 9.308

Review 2.  The effect of facility characteristics on patient safety, patient experience, and service availability for procedures in non-hospital-affiliated outpatient settings: A systematic review.

Authors:  Nancy F Berglas; Molly F Battistelli; Wanda K Nicholson; Mindy Sobota; Richard D Urman; Sarah C M Roberts
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

3.  External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality.

Authors:  Yannick Fortin; James A G Crispo; Deborah Cohen; Douglas S McNair; Donald R Mattison; Daniel Krewski
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

Review 4.  Recent advances in improving the effectiveness and reducing the complications of abortion.

Authors:  Sharon Cameron
Journal:  F1000Res       Date:  2018-12-02

5.  Intraoperative Blood Loss during Induced Abortion: A Comparison of Anesthetics.

Authors:  Camille A Clare; Gabrielle E Hatton; Neela Shrestha; Michael Girshin; Andre Broumas; Danielle Carmel; Mario A Inchiosa
Journal:  Anesthesiol Res Pract       Date:  2018-12-02

6.  The development of facility standards for common outpatient procedures and implications for the context of abortion.

Authors:  Nancy F Berglas; Sarah C M Roberts
Journal:  BMC Health Serv Res       Date:  2018-03-27       Impact factor: 2.655

7.  First trimester medication abortion practice in the United States and Canada.

Authors:  Heidi E Jones; Katharine O'Connell White; Wendy V Norman; Edith Guilbert; E Steve Lichtenberg; Maureen Paul
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.